Categoria: EM=MS

EM = MS

by | jan 25, 2017 | | 0 |

MS Research Highlights of 2016     Professor Alan Thompson highlights some of 2016’s research discoveries in MS Last updated: 24th January 2017   In the latest issue of the Lancet Neurology journal, Professor Alan...

Leia mais

EM = MS

by | jan 17, 2017 | | 0 |

Neonatal vitamin D and the risk of MS   Further evidence shows the role of vitamin D in MS risk, especially during pregnancy Last updated: 17th January 2017   Previous research has shown that vitamin D levels during...

Leia mais

EM = MS

by | nov 15, 2016 | | 0 |

Misdiagnosis of MS   Study identifies that migraine and fibromyalgia are frequently misdiagnosed as MS Last updated: 15th November 2016   MS is complex and can cause many different symptoms. There are a range of tests...

Leia mais

EM = MS

by | nov 14, 2016 | | 0 |

Alemtuzumab vs interferon in relapsing remitting MS Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS Last updated: 14th November 2016   Alemtuzumab is a...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Use of metabolic syndrome drugs in multiple sclerosis Drugs used for metabolic syndrome may reduce MS activity in people with MS and obesity Last updated: 28th September 2016   Metabolic syndrome is the medical term for a...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Bigger brains can protect against physical disability Research suggests that higher brain growth is linked to lower risk for disability progression in people with MS Last updated: 28th September 2016   Brain cells can...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Predicting long-term disability in MS Australian researchers aim to predict future worsening of disability in people with relapse-onset MS Last updated: 28th September 2016   If a neurologist could tell a person with MS, as...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Mitoxantrone and risk of cancer in MS German study asks whether recipients of mitoxantrone are more likely than the general population to develop cancers Last updated: 28th September 2016   Mitoxantrone is a chemotherapy...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

A new gene target for progressive MS A mutation in a gene called NR1H3 could increase the risk of progressive MS Last updated: 28th September 2016   A complex, and yet unknown, interaction between nature and nurture...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Effects of an immune system gene on MS subtypes and MRI HLA alleles are found to be associated with brain atrophy and a younger age of MS onset in women Last updated: 28th September 2016   A specific area on a human...

Leia mais

EM = MS

by | set 28, 2016 | | 0 |

Stem cell treatment halts MS progression Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study Last updated: 28th September 2016   The immune system is essential for life and...

Leia mais

by | set 28, 2016 | | 0 |

Safety and efficacy of siponimod for relapsing-remitting MS Siponimod study shows reduced MS activity and low relapse rates with no new safety concerns Last updated: 28th September 2016   Fingolimod is an oral tablet,...

Leia mais